MeiraGTx Holdings plc
Public company- Headquarters
- NEW YORK, New York
- Industry
- Biotechnology
- Ticker
- MGTX
- CIK
- 0001735438
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Sep 23, 2026
Executive appointmentClass I director appointed: Alan M. Sebulsky
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class I directorAlan M. Sebulsky | Sep 23, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Executive appointment
Class I director appointed: Alan M. Sebulsky
Alan M. Sebulsky was named Class I director of MeiraGTx Holdings plc, effective September 23, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 23, 2026Role: Class I director
Only one public record so far. We add events as soon as a new filing lands; watch MeiraGTx Holdings plc to get them in your digest.
Last verified Nov 8, 2026